[Medulloblastoma: towards new prognostic factors].

Abstract excerpt

Current therapeutic protocols for medulloblastoma combining, with surgery, radiation therapy and chemotherapy allow 5-year survival rates of over 50%. However these therapies induce mainly in children long-term adverse effects, which produce a therapeutic dilemma emphasizing the need for reliable prognostic factors in order to adapt the treatment modalities to the degree of the tumor's aggressiveness....

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Flow Cytometry
• Share to Neoplasm Invasiveness
• Share to Phenotype